3D bioprinting of


Journal

Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964

Informations de publication

Date de publication:
06 06 2023
Historique:
received: 18 01 2023
accepted: 26 05 2023
medline: 7 6 2023
pubmed: 27 5 2023
entrez: 26 5 2023
Statut: epublish

Résumé

Biofilm-associated infections are causing over half a million deaths each year, raising the requirement for innovative therapeutic approaches. For developing novel therapeutics against bacterial biofilm infections, complex

Identifiants

pubmed: 37236174
doi: 10.1088/1758-5090/acd95e
doi:

Substances chimiques

Hydrogels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Samy Aliyazdi (S)

Department of Drug Delivery, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Sarah Frisch (S)

Department of Drug Delivery, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Alberto Hidalgo (A)

Department of Drug Delivery, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Charite-Universitätsmedizin Berlin, Institute of Functional Anatomy, Philippstraße 12, 10115 Berlin, Germany.

Nicolas Frank (N)

Department of Microbial Natural Products, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.

Daniel Krug (D)

Department of Microbial Natural Products, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Rolf Müller (R)

Department of Microbial Natural Products, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Ulrich F Schaefer (UF)

Saarland University, 66123 Saarbrücken, Germany.

Thomas Vogt (T)

University Clinic Homburg, Clinic for Dermatology, Kirrberger Str., 66424 Homburg, Germany.

Brigitta Loretz (B)

Department of Drug Delivery, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Claus-Michael Lehr (CM)

Department of Drug Delivery, Helmholtz Center for Infection Research, Helmholtz-Institute for Pharmaceutical Research Saarland, Campus E8 1, 66123 Saarbrücken, Germany.
Saarland University, 66123 Saarbrücken, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH